Fund Holdings — SUPERSTRING CAPITAL MANAGEMENT LP

Total Portfolio Value:
$111.83M
Total Bought:
$64.52M
Total Sold:
$32.39M
Net Transaction:
+$32.13M
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Zai Lab LimitedADR(ZLAB)215,178626,932+411,754$3.73M$15.13M13.53%+$11.41M
Cytokinetics, Incorporated(CYTK)187,633215,798+28,165$10.17M$11.39M10.19%+$1.23M
Terns Pharmaceuticals Inc956,5421,348,546+392,004$6.51M$11.25M10.06%+$4.73M
Structure Therapeutics IncADS0227,047+227,047$0$9.97M8.91%+$9.97M
ORIC Pharmaceuticals, Inc.(ORIC)0949,522+949,522$0$9.73M8.70%+$9.73M
Instil Bio, Inc.(TIL)0107,545+107,545$0$7.24M6.47%+$7.24M
NovoCure Limited(NVCR)66,892392,711+325,819$1.15M$6.14M5.49%+$4.99M
BridgeBio Pharma, Inc.(BBIO)219,837226,684+6,847$5.57M$5.77M5.16%+$202.9K
Fate Therapeutics, Inc.(FATE)497,3601,466,934+969,574$1.63M$5.13M4.59%+$3.50M
Capricor Therapeutics, Inc.(CAPR)0337,347+337,347$0$5.13M4.59%+$5.13M
Tango Therapeutics, Inc.(TNGX)115,571599,048+483,477$991.6K$4.61M4.12%+$3.62M
89bio Inc680,403595,203-85,200$5.45M$4.40M3.94%-$1.05M
Nkarta, Inc.(NKTX)875,999740,294-135,705$5.18M$3.35M2.99%-$1.83M
Legend Biotech CorporationADS(LEGN)154,66560,515-94,150$6.85M$2.95M2.64%-$3.90M
Zenas BioPharma, Inc.(ZBIO)0111,605+111,605$0$1.89M1.69%+$1.89M
Allogene Therapeutics Inc689,912478,115-211,797$1.61M$1.34M1.20%-$268.8K
Spyre Therapeutics, Inc.(SYRE)45,57137,287-8,284$1.07M$1.10M0.98%+$25.2K
Savara Inc.(SVRA)200,000200,0000$806.0K$848.0K0.76%+$42.0K
Biomea Fusion, Inc.(BMEA)167,11083,554-83,556$752.0K$843.9K0.75%+$91.9K
Tourmaline Bio Inc95,22929,104-66,125$1.22M$748.3K0.67%-$476.4K
Zura Bio LimitedCL A(ZURA)156,626156,6260$548.2K$635.9K0.57%+$87.7K
Cabaletta Bio, Inc.(CABA)139,895131,795-8,100$1.05M$622.1K0.56%-$424.3K
Corbus Pharmaceuticals Holdings, Inc.(CRBP)56,46825,401-31,067$2.56M$524.0K0.47%-$2.03M
Immunovant, Inc.(IMVT)012,447+12,447$0$354.9K0.32%+$354.9K
Cullinan Therapeutics, Inc.(CGEM)020,840+20,840$0$348.9K0.31%+$348.9K
Lakeshore Biopharma Co Ltd307,920307,9200$199.5K$212.2K0.19%+$12.7K
Climb Bio, Inc.(CLYM)033,824+33,824$0$172.2K0.15%+$172.2K
Allakos Inc940,5780-940,578$940.6K$0—-$940.6K
Apogee Therapeutics Inc36,9280-36,928$1.45M$0—-$1.45M
Arcellx Inc
COMMON STOCK
59,1330-59,133$3.26M$0—-$3.26M
Arrowhead Pharmaceuticals, Inc.(ARWR)111,1330-111,133$2.89M$0—-$2.89M
Atyr Pharma Inc313,0280-313,028$488.3K$0—-$488.3K
BeOne Medicines AGADR(ONC)12,5080-12,508$1.78M$0—-$1.78M
COMPASS Pathways plcADS(CMPS)32,4970-32,497$196.3K$0—-$196.3K
CytomX Therapeutics, Inc.(CTMX)1,151,5180-1,151,518$1.40M$0—-$1.40M
EyePoint, Inc.(EYPT)37,8380-37,838$329.2K$0—-$329.2K
Karyopharm Therapeutics Inc.(KPTI)534,4850-534,485$463.7K$0—-$463.7K
Keros Therapeutics, Inc.(KROS)74,2880-74,288$3.39M$0—-$3.39M
Kura Oncology, Inc.(KURA)36,2420-36,242$746.2K$0—-$746.2K
Marinus Pharmaceuticals Inc261,8610-261,861$306.4K$0—-$306.4K
Mersana Therapeutics Inc110,0730-110,073$221.2K$0—-$221.2K
Newamsterdam Pharma Company
ORDINARY SHARES
64,2130-64,213$1.23M$0—-$1.23M
PepGen Inc.(PEPG)29,2490-29,249$466.8K$0—-$466.8K
Perspective Therapeutics, Inc.(CATX)87,6380-87,638$873.8K$0—-$873.8K
Pyxis Oncology, Inc.(PYXS)484,4430-484,443$1.60M$0—-$1.60M
Spruce Biosciences Inc77,9920-77,992$40.4K$0—-$40.4K
Syros Pharmaceuticals Inc37,7890-37,789$195.0K$0—-$195.0K
Page 1 of 1
SUPERSTRING CAPITAL MANAGEMENT LP — 13F Holdings — Q3 2024 | TickerTrail